ENTITY
Sinopharm Group

Sinopharm Group (1099 HK)

171
Analysis
Health Care • China
Sinopharm Group is a leading Chinese distributor and retailer of pharmaceutical and healthcare products, medical devices, and a supply chain service provider. The company also engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. It was incorporated in January 2003 and is headquartered in Shanghai, China.
more
•21 Feb 2015 00:02

Opening of E-commerce Channel to Change China's Drug Market

Numerous press outlets report that China’s Food & Drug Administration (CFDA) will release regulations permitting online sales of...

Share
•05 Feb 2015 16:01

Introducing Long Term Leaders - Focussed Insights for your Core Holdings

We are pleased to announce the roll out of our latest content vertical: Long Term Leaders. Under this category,  we have identified companies that...

Logo
497 Views
Share
bearish•InventisBio
•26 Feb 2026 09:40

InventisBio (益方生物) A+H: Moderate Innovation in Crowded Spaces

​China-based biotech InventisBio seeks to raise $100 million through Hong Kong listing with CITIC as sole sponsor. We look at its drug pipelines,...

Logo
319 Views
Share
•09 Feb 2026 05:48

Hang Seng Index (HSI) Rebalance Preview: Inclusion Candidates for Mar26

We highlight 8 potential adds to the HSI in March. CATL is still a high prob add along with Healthcare names. Estimated turnover is 4.1% and trade...

Logo
1.1k Views
Share
•29 Jan 2026 08:55

China TCM (570.HK) - About the 2025 Profit Warning and the Outlook

​China TCM will shift from a profit into a loss in 2025, mainly due to VBP/impairment. Taiji will collaborate with CNPGC to resolve horizontal...

Logo
364 Views
Share
x